Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Marmoset Research - Scope and Challenges
Published on: June 9, 2023
Relationship between amikacin blood concentration and ototoxicity in low birth weight infants
Aiju Endo1, Atsushi Nemoto2, Kazumi Hanawa1
1Department of Pharmacy, Yamanashi Prefectural Central Hospital, Yamanashi, 400-8506, Japan.
Insights
Amikacin (AMK) once daily dosing shows therapeutic effect in low birth weight infants. However, trough concentrations of AMK ≥10 μg/mL are linked to ototoxicity, indicating a need for careful monitoring.
Area of Science:
- Neonatal pharmacology
- Pediatric infectious diseases
- Clinical pharmacokinetics
Background:
- Amikacin (AMK) is a critical antibiotic for severe infections in low birth weight (LBW) infants.
- Limited evidence exists on the efficacy and safety of once-daily (OD) AMK dosing in LBW neonates.
- Therapeutic drug monitoring is essential for optimizing antibiotic therapy in vulnerable infant populations.
Purpose of the Study:
- To evaluate the therapeutic effectiveness and safety of once-daily Amikacin (AMK) administration in low birth weight (LBW) infants.
- To investigate the relationship between AMK pharmacokinetic parameters and adverse events, specifically renal dysfunction and ototoxicity.
- To determine optimal AMK trough concentration thresholds for preventing toxicity in LBW neonates.
Main Methods:
- Therapeutic drug monitoring of AMK in 20 LBW infants with severe infections.
- Analysis of clinical data for treatment effectiveness, renal dysfunction (serum creatinine), and ototoxicity.
- Pharmacokinetic assessment including peak and trough AMK concentrations.
- Statistical comparison of patient groups based on AMK trough concentration cut-offs.
Main Results:
- All infants demonstrated therapeutic effectiveness with AMK OD treatment.
- No significant renal dysfunction was observed, as indicated by stable serum creatinine levels.
- Ototoxicity occurred in 4 infants, with 3 of these having AMK trough concentrations ≥10 μg/mL.
- A trough concentration ≥10 μg/mL was significantly associated with ototoxicity, independent of AMK dose.
Conclusions:
- Once-daily Amikacin is effective for severe infections in LBW infants.
- Monitoring AMK trough concentrations is crucial to mitigate the risk of ototoxicity.
- A target trough concentration below 10 μg/mL may be necessary to ensure safety in LBW neonates.
Abstract:
Amikacin (AMK) is used as empiric therapy for severe infections such as sepsis in low birth weight (LBW) infants. AMK administered once daily (OD) in adults is reported to be therapeutically effective and prevent side effects, however, evidence on AMK administration in LBW infants is limited, with no clear indications of effectiveness. We performed therapeutic drug monitoring analysis of 20 infants treated with AMK OD for severe infections such as bacteremia. Treatment effectiveness was admitted by the patients' medical records, and side effects of renal dysfunction and ototoxicity were investigated. The mean gestational age was 30.4 ± 5 weeks and mean body weight (Bw) was 1280.2 ± 809.8 g. The mean AMK dose was 14.1 ± 2.6 mg/kg and mean administration period was 10.1 ± 4.1 days. Blood concentration was measured 6.3 ± 2.3 days after AMK administration; mean peak and trough concentrations were 29.1 ± 7.5 μg/mL and 7.6 ± 6.9 μg/mL, respectively. Additionally, therapeutic effect was observed in all patients, and no significant change in serum creatinine (CRE) concentration (a marker of renal dysfunction) was observed, suggesting no renal dysfunction. Ototoxicity was observed in 4 patients, 3 of whom had trough concentrations ≥10 μg/mL. When we categorized patients into two groups using a trough cut-off value of 10 μg/mL, no difference in AMK dose was observed. However, there were significant differences in peak concentration, Bw, volume of distribution and CRE. Our findings suggest AMK trough concentration ≥10 μg/mL significantly affects ototoxicity in neonates.
Related Concept Videos
Birth Control Methods
Relationship Formation
Concentration and Rate Law
For example, in a generic reaction aA + bB ⟶ products, where a and b are stoichiometric coefficients, the rate law can be written as:
Ending Relationships
Weighted Mean
For example, consider the number of goals scored in the matches of a tournament. While computing the average number of goals scored in the tournament, it may be more important to...
Concentration Cells
Consider the following voltaic cell:

